نبذة مختصرة : This research was funded by the Spanish Ministry of Economy and Competitiveness—Carlos III Institute of Health cofunded by FEDER funds/European Regional Development Fund (ERDF)—a way to build Europe (grants PI17/01280, PI11/01810, PI14/01219, PI11/02213, PI09/1662, PI15/00966, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, Rio Hortega CM13/00232, Juan de la Cierva de Incorporacion IJCI-2016-29502 and SV-09-CLINIC-1), Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP, Spain) and Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), CERCA Programme/Generalitat de Catalunya for institutional support(2017SGR1085), and European Regional Development Fund-ERDF/FEDER. The ICGC CLL-Genome Project was funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII), PMP15/00007 which is part of Plan Nacional de I+D+I and is co-financed by the ISCIII-Sub-Directorate General for Evaluation and the European Regional Development Fund (FEDER-“Una manera de Hacer Europa”) and CIBERONC. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. ; Flores, J.C., Gracia-Lavedan, E., Benavente, Y., Amiano, P., Romaguera, D., Costas, L., Robles, C., Gonzalez-Barca, E., de la Banda, E., Alonso, E., Aymerich, M., Campo, E., Dierssen-Sotos, T., Marcos-Gragera, R., Rodriguez-Suarez, M.M., Solans, M., Gimeno, E., Martin, P.G., Aragones, N., Shivappa, N., Hébert, J.R., Pollan, M., Kogevinas, M., de Sanjose, S., Castaño-Vinyals, G., Casabonne, D.
Processing Request
No Comments.